Literature DB >> 17169841

Oxidative stress and protein oxidation in pseudoexfoliation syndrome.

Ramazan Yağci1, Ahmet Gürel, Ibrahim Ersöz, Uğgur C Keskin, Ibrahim F Hepşen, Sunay Duman, Ramazan Yiğitoğlu.   

Abstract

PURPOSE: To investigate the oxidant/antioxidant status and protein oxidation in pseudoexfoliation syndrome.
METHODS: The activity of serum superoxide dismutase (SOD) and the levels of serum malondialdehyde (MDA) and protein carbonyl (PC) were measured in 50 patients with pseudoexfoliation (PEX) and in 55 healthy controls.
RESULTS: There was significant difference in the SOD activity in PEX group compared with the control group (p < 0.001). In addition, MDA and PC levels were significantly higher in patients than in the controls (p < 0.001).
CONCLUSIONS: Decrease in SOD activity and the higher levels of MDA and PC indicate increased oxidative stress. Our results suggest a possible role of oxidative stress in pathology of PEX syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17169841     DOI: 10.1080/02713680601001319

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  17 in total

1.  Serum prolidase activity and oxidative stress in patients with pseudoexfoliation syndrome.

Authors:  Mehmet Tetikoğlu; Haci Murat Sağdik; Serdar Aktas; Fatma Uçar; Fatih Özcura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-15       Impact factor: 3.117

2.  Evaluation of serum and aqueous humor klotho levels in pseudoexfoliation syndrome, pseudoexfoliation and primary open-angle glaucoma.

Authors:  Ecem Onder Tokuc; Nursen Yuksel; Hale Maral Kır; Esra Acar
Journal:  Int Ophthalmol       Date:  2021-03-18       Impact factor: 2.031

3.  Aqueous humor and serum levels of 4-hydroxynonenal and 8-hydroxy-2'deoxyguanosine in pseudoexfoliation syndrome and glaucoma.

Authors:  Nurullah Koçak; Ertuğrul Can; Volkan Yeter; Mustafa Turunç; Mustafa Subaşı; Leyla Niyaz; Bahattin Avcı
Journal:  Int Ophthalmol       Date:  2022-10-04       Impact factor: 2.029

Review 4.  Oxidative stress and potential applications of free radical scavengers in glaucoma.

Authors:  Mutay Aslan; Serdar Dogan; Ertan Kucuksayan
Journal:  Redox Rep       Date:  2013-03-06       Impact factor: 4.412

5.  The Relationship between caffeine and coffee consumption and exfoliation glaucoma or glaucoma suspect: a prospective study in two cohorts.

Authors:  Louis R Pasquale; Janey L Wiggs; Walter C Willett; Jae H Kang
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-21       Impact factor: 4.799

6.  A prospective study of folate, vitamin B₆, and vitamin B₁₂ intake in relation to exfoliation glaucoma or suspected exfoliation glaucoma.

Authors:  Jae H Kang; Stephanie J Loomis; Janey L Wiggs; Walter C Willett; Louis R Pasquale
Journal:  JAMA Ophthalmol       Date:  2014-05       Impact factor: 7.389

7.  Total oxidative stress, paraoxonase and arylesterase levels at patients with pseudoexfoliation syndrome and pseudoexfoliative glaucoma.

Authors:  Feyza Dursun; Ayse Vural Ozec; Huseyin Aydin; Aysen Topalkara; Ayhan Dursun; Mustafa Ilker Toker; Haydar Erdogan; Mustafa Kemal Arici
Journal:  Int J Ophthalmol       Date:  2015-10-18       Impact factor: 1.779

8.  Quantitative analysis of SOD2, ALDH1A1 and MGST1 messenger ribonucleic acid in anterior lens epithelium of patients with pseudoexfoliation syndrome.

Authors:  Barbara Strzalka-Mrozik; Lilianna Prudlo; Malgorzata W Kimsa; Magdalena C Kimsa; Malgorzata Kapral; Malgorzata Nita; Urszula Mazurek
Journal:  Mol Vis       Date:  2013-06-12       Impact factor: 2.367

9.  The evaluation of the oxidative stress parameters in patients with primary angle-closure glaucoma.

Authors:  Dong Chang; Qian Sha; Xuefei Zhang; Peipei Liu; Shengzhong Rong; Tao Han; Ping Liu; Hongzhi Pan
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

10.  Serum Uric Acid, Alanine Aminotransferase, Hemoglobin and Red Blood Cell Count Levels in Pseudoexfoliation Syndrome.

Authors:  Hüseyin Simavlı; Yasin Yücel Bucak; Mehmet Tosun; Mesut Erdurmuş
Journal:  J Ophthalmol       Date:  2015-05-13       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.